Edwards Lifesciences
921 hedge funds and large institutions have $32B invested in Edwards Lifesciences in 2019 Q2 according to their latest regulatory filings, with 95 funds opening new positions, 296 increasing their positions, 357 reducing their positions, and 83 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
3.87% less ownership
Funds ownership: 253.32% → 249.45% (-3.9%)
16% less funds holding in top 10
Funds holding in top 10: 25 → 21 (-4)
17% less repeat investments, than reductions
Existing positions increased: 296 | Existing positions reduced: 357
Holders
921
Holding in Top 10
21
Calls
$224M
Puts
$169M
Top Buyers
| 1 | +$721M | |
| 2 | +$518M | |
| 3 | +$281M | |
| 4 |
HM
HealthCor Management
New York
|
+$115M |
| 5 |
Bessemer Group
Woodbridge,
New Jersey
|
+$92.9M |
Top Sellers
| 1 | -$534M | |
| 2 | -$300M | |
| 3 | -$129M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$119M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$112M |